Cannabis for medicine and food: A benefit vs risk critical appraisal

• Cannabidiol (CBD) and Δ-9-tetrahydrocannabinol (THC) in cannabis possess nutritional and therapeutic benefits against chronic pain, anxiety, vomiting, and weight loss. • Chronic use of CBD and especially, THC, is associated with health risks, including physiological, psychiatric, addiction, and dependency issues. • The complex interactions of the cannabinoids with the endocannabinoid system (ECS) are responsible for benefits and associated risks. • A thorough elucidation of the multifaceted mechanisms of the binding of CBD and THC to the ECS and downstream effects will help in maximizing the food and medicinal applications of cannabis. • Scientific evidence must support the current regulations for the safe and responsible use of cannabis for medical and food purposes. The use of cannabis for health purposes continues to gain significant attention due to the presence of important phytochemicals, chiefly, cannabidiol (CBD) and Δ-9-tetrahydrocannabinol (THC). The therapeutic potentials of CBD and THC in the management of cancer-associated chronic pain, anxiety, stress, nausea, vomiting, and weight loss are well-reported. These benefits are triggered by the intricate interactions of the cannabinoids with their receptors in the endocannabinoid system (ECS) leading to pharmacodynamic actions. Conversely, the possible physiological, psychiatric, cognition, addiction, and dependency risks, especially due to chronic intake of THC, are huge limitations in fully harnessing the clinical utility of cannabis. Here, an up-to-date critique of the potential merits and adverse effects of cannabis and cannabis-containing products is provided. A thorough knowledge of the interplay between CBD, THC, and the ECS gives deep insights that can be explored for consumer health without the attendant complications. Future directions in cannabis research must be guided by a nuanced understanding of its molecular mechanisms of action and potential risks, enabling the development of targeted and effective medical interventions. Besides, standardized regulations and comprehensive education that are backed by empirical evidence are crucial to fostering the safe and responsible use of cannabis for food or medicine.

Authors

Institutions

Publication Details

Journal
South African Journal of Botany
Published
2024-10-11
DOI
https://doi.org/10.1016/j.sajb.2024.09.069
Citations
5
Primary Topic
Cannabis and Cannabinoid Research
Type
article
Field-Weighted Citation Impact
2.24

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cannabis for medicine and food: A benefit vs risk critical appraisal

Murendeni Nethengwe, Y Maphosa, BO Ahiante, AB Oyenihi
5 citations
South African Journal of Botany
Cannabis and Cannabinoid Research
2.24
article

Cannabis for medicine and food: A benefit vs risk critical appraisal

Murendeni Nethengwe, Y Maphosa, BO Ahiante, AB Oyenihi
article en
5 citations

Abstract

• Cannabidiol (CBD) and Δ-9-tetrahydrocannabinol (THC) in cannabis possess nutritional and therapeutic benefits against chronic pain, anxiety, vomiting, and weight loss. • Chronic use of CBD and especially, THC, is associated with health risks, including physiological, psychiatric, addiction, and dependency issues. • The complex interactions of the cannabinoids with the endocannabinoid system (ECS) are responsible for benefits and associated risks. • A thorough elucidation of the multifaceted mechanisms of the binding of CBD and THC to the ECS and downstream effects will help in maximizing the food and medicinal applications of cannabis. • Scientific evidence must support the current regulations for the safe and responsible use of cannabis for medical and food purposes. The use of cannabis for health purposes continues to gain significant attention due to the presence of important phytochemicals, chiefly, cannabidiol (CBD) and Δ-9-tetrahydrocannabinol (THC). The therapeutic potentials of CBD and THC in the management of cancer-associated chronic pain, anxiety, stress, nausea, vomiting, and weight loss are well-reported. These benefits are triggered by the intricate interactions of the cannabinoids with their receptors in the endocannabinoid system (ECS) leading to pharmacodynamic actions. Conversely, the possible physiological, psychiatric, cognition, addiction, and dependency risks, especially due to chronic intake of THC, are huge limitations in fully harnessing the clinical utility of cannabis. Here, an up-to-date critique of the potential merits and adverse effects of cannabis and cannabis-containing products is provided. A thorough knowledge of the interplay between CBD, THC, and the ECS gives deep insights that can be explored for consumer health without the attendant complications. Future directions in cannabis research must be guided by a nuanced understanding of its molecular mechanisms of action and potential risks, enabling the development of targeted and effective medical interventions. Besides, standardized regulations and comprehensive education that are backed by empirical evidence are crucial to fostering the safe and responsible use of cannabis for food or medicine.

South African Journal of BotanyVol. 175
Cape Peninsula University of Technology (ZA), Medical Diagnostic Laboratories (United States) (US), University of Pretoria (ZA)
National Research Foundation
Zero hunger
Openalex Percentile: Top 12%
Cannabis and Cannabinoid Research
2.24
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.